(Total Views: 150)
Posted On: 02/23/2022 3:09:22 PM
Post# of 25613
$NBIO Pritumumab is a proprietary monoclonal antibody (mAb) targeting a novel antigen on cancer cells.
Pritumumab has received FDA orphan drug status
https://www.nascentbiotech.com/
Pritumumab has received FDA orphan drug status
https://www.nascentbiotech.com/
(0)
(0)
